• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of cardiovascular disease risk factors with coronary artery calcium volume versus density.心血管疾病危险因素与冠状动脉钙体积与密度的关系。
Heart. 2018 Jan;104(2):135-143. doi: 10.1136/heartjnl-2017-311536. Epub 2017 Aug 16.
2
Coronary Artery Calcium Volume and Density: Potential Interactions and Overall Predictive Value: The Multi-Ethnic Study of Atherosclerosis.冠状动脉钙体积和密度:潜在的相互作用和整体预测价值:动脉粥样硬化的多民族研究。
JACC Cardiovasc Imaging. 2017 Aug;10(8):845-854. doi: 10.1016/j.jcmg.2017.04.018.
3
Calcium density of coronary artery plaque and risk of incident cardiovascular events.冠状动脉斑块钙密度与心血管事件发生风险。
JAMA. 2014 Jan 15;311(3):271-8. doi: 10.1001/jama.2013.282535.
4
Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis.颈动脉斑块评分与冠状动脉钙化评分对心血管疾病事件预测作用的比较:动脉粥样硬化多族裔研究
J Am Heart Assoc. 2017 Feb 14;6(2):e005179. doi: 10.1161/JAHA.116.005179.
5
Associations of cardiovascular disease risk factors with abdominal aortic calcium volume and density: The Multi-Ethnic Study of Atherosclerosis (MESA).心血管疾病危险因素与腹主动脉钙化体积和密度的关联:动脉粥样硬化多民族研究(MESA)
Atherosclerosis. 2016 Dec;255:54-58. doi: 10.1016/j.atherosclerosis.2016.10.036. Epub 2016 Oct 20.
6
Greater Volume but not Higher Density of Abdominal Aortic Calcium Is Associated With Increased Cardiovascular Disease Risk: MESA (Multi-Ethnic Study of Atherosclerosis).腹主动脉钙化体积增大而非密度增加与心血管疾病风险升高相关:动脉粥样硬化多民族研究(MESA)
Circ Cardiovasc Imaging. 2016 Nov;9(11). doi: 10.1161/CIRCIMAGING.116.005138.
7
Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease.晚期慢性肾脏病患者冠状动脉钙密度与死亡率之间呈反 J 形关系。
Nephrol Dial Transplant. 2020 Jul 1;35(7):1202-1211. doi: 10.1093/ndt/gfy352.
8
Associations of abdominal muscle area and density with coronary artery calcium volume and density: The multi-ethnic study of atherosclerosis.腹内横截面积和密度与冠状动脉钙体积和密度的相关性研究:动脉粥样硬化的多民族研究。
Metabolism. 2020 Jun;107:154230. doi: 10.1016/j.metabol.2020.154230. Epub 2020 Apr 13.
9
Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis.腹主动脉钙、冠状动脉钙与心血管疾病发病和死亡风险:动脉粥样硬化的多种族研究。
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1574-9. doi: 10.1161/ATVBAHA.114.303268. Epub 2014 May 8.
10
Density and morphology of coronary artery calcium for the prediction of cardiovascular events: insights from the Framingham Heart Study.冠状动脉钙密度和形态学对心血管事件的预测:弗雷明汉心脏研究的见解。
Eur Radiol. 2019 Nov;29(11):6140-6148. doi: 10.1007/s00330-019-06223-7. Epub 2019 May 2.

引用本文的文献

1
Bridging Prevention and Imaging: The Influence of Statins on CAC and CCTA Findings.连接预防与成像:他汀类药物对冠状动脉钙化(CAC)和冠状动脉CT血管造影(CCTA)结果的影响
Curr Atheroscler Rep. 2025 Apr 8;27(1):50. doi: 10.1007/s11883-025-01287-x.
2
Structural and social determinants of health: The multi-ethnic study of atherosclerosis.健康的结构和社会决定因素:动脉粥样硬化的多种族研究。
PLoS One. 2024 Nov 18;19(11):e0313625. doi: 10.1371/journal.pone.0313625. eCollection 2024.
3
Association of Oral Anticoagulant Therapy with the Prevalence and Severity of Vascular Calcification among Patients with Atrial Fibrillation: A Cohort Study.口服抗凝治疗与心房颤动患者血管钙化的患病率及严重程度的关联:一项队列研究
ACS Pharmacol Transl Sci. 2024 Apr 9;7(5):1262-1269. doi: 10.1021/acsptsci.3c00307. eCollection 2024 May 10.
4
Coronary artery calcification: concepts and clinical applications.冠状动脉钙化:概念与临床应用
Ann Med Surg (Lond). 2024 Apr 3;86(5):2848-2855. doi: 10.1097/MS9.0000000000002016. eCollection 2024 May.
5
Screening for Subclinical Atherosclerosis and the Prediction of Cardiovascular Events in People with Type 1 Diabetes.1型糖尿病患者亚临床动脉粥样硬化的筛查及心血管事件的预测
J Clin Med. 2024 Feb 15;13(4):1097. doi: 10.3390/jcm13041097.
6
Long-term all-cause death prediction by coronary, aortic, and valvular calcification in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者冠状动脉、主动脉及瓣膜钙化对长期全因死亡的预测作用
BMC Cardiovasc Disord. 2024 Feb 19;24(1):117. doi: 10.1186/s12872-024-03758-6.
7
A fully automated deep learning approach for coronary artery segmentation and comprehensive characterization.一种用于冠状动脉分割和全面特征描述的全自动深度学习方法。
APL Bioeng. 2024 Jan 23;8(1):016103. doi: 10.1063/5.0181281. eCollection 2024 Mar.
8
Artificial Intelligence Empowered Nuclear Medicine and Molecular Imaging in Cardiology: A State-of-the-Art Review.人工智能助力心脏病学中的核医学与分子影像:现状综述
Phenomics. 2023 Dec 5;3(6):586-596. doi: 10.1007/s43657-023-00137-7. eCollection 2023 Dec.
9
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies.无症状人群体内亚临床动脉粥样硬化的评估:适合生物标志物和孟德尔随机化研究的测量方法。
Arterioscler Thromb Vasc Biol. 2024 Jan;44(1):24-47. doi: 10.1161/ATVBAHA.123.320138. Epub 2023 Nov 21.
10
Coronary calcium density in relation to coronary heart disease and cardiovascular disease in adults with diabetes or metabolic syndrome: the Multi-ethnic Study of Atherosclerosis (MESA).成人糖尿病或代谢综合征患者的冠状动脉钙密度与冠心病和心血管疾病的关系:动脉粥样硬化多民族研究(MESA)。
BMC Cardiovasc Disord. 2022 Dec 9;22(1):536. doi: 10.1186/s12872-022-02956-4.

本文引用的文献

1
Impact of statins on serial coronary calcification during atheroma progression and regression.他汀类药物对动脉粥样硬化进展和消退过程中冠状动脉钙化的影响。
J Am Coll Cardiol. 2015 Apr 7;65(13):1273-1282. doi: 10.1016/j.jacc.2015.01.036.
2
Calcium density of coronary artery plaque and risk of incident cardiovascular events.冠状动脉斑块钙密度与心血管事件发生风险。
JAMA. 2014 Jan 15;311(3):271-8. doi: 10.1001/jama.2013.282535.
3
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会心血管风险评估指南:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
4
Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT).在退伍军人事务部糖尿病试验(VADT)中,使用他汀类药物会增加血管钙化的进展。
Diabetes Care. 2012 Nov;35(11):2390-2. doi: 10.2337/dc12-0464. Epub 2012 Aug 8.
5
The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy.无症状人群冠状动脉钙化与传统危险因素及居住在市中心的关系:丹风险研究的一个子研究。
J Intern Med. 2012 May;271(5):444-50. doi: 10.1111/j.1365-2796.2011.02486.x. Epub 2011 Dec 20.
6
Coronary calcium as a predictor of coronary events in four racial or ethnic groups.冠状动脉钙化作为四个种族或族裔群体中冠状动脉事件的预测指标。
N Engl J Med. 2008 Mar 27;358(13):1336-45. doi: 10.1056/NEJMoa072100.
7
General cardiovascular risk profile for use in primary care: the Framingham Heart Study.用于初级保健的一般心血管风险概况:弗雷明汉心脏研究
Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
8
Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA).无症状受试者冠状动脉钙化进展的危险因素:动脉粥样硬化多民族研究(MESA)的结果
Circulation. 2007 May 29;115(21):2722-30. doi: 10.1161/CIRCULATIONAHA.106.674143. Epub 2007 May 14.
9
Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial.尽管进行了强化降脂治疗,冠状动脉钙化仍在进展:一项随机对照试验。
Heart. 2006 Sep;92(9):1207-12. doi: 10.1136/hrt.2005.080929. Epub 2006 Jan 31.
10
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.阿托伐他汀强化降脂治疗与标准降脂治疗对钙化性冠状动脉粥样硬化12个月进展的影响:一项多中心、随机、双盲试验
Circulation. 2006 Jan 24;113(3):427-37. doi: 10.1161/CIRCULATIONAHA.105.568147. Epub 2006 Jan 16.

心血管疾病危险因素与冠状动脉钙体积与密度的关系。

Association of cardiovascular disease risk factors with coronary artery calcium volume versus density.

机构信息

Division of Preventive Medicine, Department of Family Medicine and Public Health, University of California, San Diego, California, USA.

Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, California, USA.

出版信息

Heart. 2018 Jan;104(2):135-143. doi: 10.1136/heartjnl-2017-311536. Epub 2017 Aug 16.

DOI:10.1136/heartjnl-2017-311536
PMID:28814488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6004322/
Abstract

OBJECTIVES

Recently, the density score of coronary artery calcium (CAC) has been shown to be associated with a lower risk of cardiovascular disease (CVD) events at any level of CAC volume. Whether risk factors for CAC volume and CAC density are similar or distinct is unknown. We sought to evaluate the associations of CVD risk factors with CAC volume and CAC density scores.

METHODS

Baseline measurements from 6814 participants free of clinical CVD were collected for the Multi-Ethnic Study of Atherosclerosis. Participants with detectable CAC (n=3398) were evaluated for this study. Multivariable linear regression models were used to evaluate independent associations of CVD risk factors with CAC volume and CAC density scores.

RESULTS

Whereas most CVD risk factors were associated with higher CAC volume scores, many risk factors were associated with CAC density scores. For example, diabetes was associated with a higher natural logarithm () transformed CAC volume score (standardised β=0.44 (95% CI 0.31 to 0.58) ln-units) but a lower CAC density score (β=-0.07 (-0.12 to -0.02) density units). Chinese, African-American and Hispanic race/ethnicity were each associated with lower CAC volume scores (β=-0.62 (-0.83to -0.41), -0.52 (-0.64 to -0.39) and -0.40 (-0.55 to -0.26) ln-units, respectively) and higher CAC density scores (β= 0.41 (0.34 to 0.47), 0.18 (0.12 to 0.23) and 0.21 (0.15 to 0.26) density units, respectively) relative to non-Hispanic White.

CONCLUSIONS

In a cohort free of clinical CVD, CVD risk factors are differentially associated with CAC volume and density scores, with many CVD risk factors associated with the CAC density score after controlling for the CAC volume score. These findings suggest complex associations between CVD risk factors and these components of CAC.

摘要

目的

最近,冠状动脉钙(CAC)密度评分已被证明与任何 CAC 体积水平的心血管疾病(CVD)事件风险降低相关。CAC 体积和 CAC 密度的危险因素是否相似或不同尚不清楚。我们试图评估 CVD 危险因素与 CAC 体积和 CAC 密度评分的相关性。

方法

从无临床 CVD 的 6814 名参与者中收集了基线测量值,用于进行多民族动脉粥样硬化研究。对可检测 CAC(n=3398)的参与者进行了此项研究。使用多变量线性回归模型评估 CVD 危险因素与 CAC 体积和 CAC 密度评分的独立相关性。

结果

虽然大多数 CVD 危险因素与 CAC 体积评分升高相关,但许多危险因素与 CAC 密度评分相关。例如,糖尿病与较高的自然对数()转换 CAC 体积评分(标准化β=0.44(95%CI 0.31 至 0.58)ln-单位)相关,但与较低的 CAC 密度评分(β=-0.07(-0.12 至 -0.02)密度单位)相关。中国、非裔美国人和西班牙裔种族/民族分别与较低的 CAC 体积评分(β=-0.62(-0.83 至 -0.41)、-0.52(-0.64 至 -0.39)和-0.40(-0.55 至 -0.26)ln 单位)和较高的 CAC 密度评分(β=0.41(0.34 至 0.47)、0.18(0.12 至 0.23)和 0.21(0.15 至 0.26)密度单位)相关,与非西班牙裔白人相比。

结论

在无临床 CVD 的队列中,CVD 危险因素与 CAC 体积和密度评分存在差异相关性,在控制 CAC 体积评分后,许多 CVD 危险因素与 CAC 密度评分相关。这些发现表明 CVD 危险因素与 CAC 这些成分之间存在复杂的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc8/6004322/60a8885c631f/nihms973948f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc8/6004322/60a8885c631f/nihms973948f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc8/6004322/60a8885c631f/nihms973948f1.jpg